Genmab — Oktober 2018
-
Hvis Nasdaq for mistanke om en lovovertrædelse, er de forpligtigede til at anmelde det til den relevante nationale kompetente myndighed, hvilket i Danmark er Finanstilsynet. Det behøver dog ikke ske i realtid, men når Nasdaq har haft mulighed for nærmere at afdække de relevante forhold i sagen.
Med venlig hilsen
Brian Mikkelsen -
There will also be data for …… and ofatumumab (OMB157), https://www.nasdaq.com/article/novartis-to-present-33-scientific-abstracts-20181010-00038
-
-
TA versus FA: http://www.proinvestor.com/debat/76350
-
-
I think ofa will be self-administered what ever they choose prefilled syringes or autoinjectors. https://www.sciencedirect.com/topics/medicine-and-dentistry/autoinjector
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

